Cotton O'Neil Cancer Center / Stormont Vail Health

Summary

Cotton O'Neil Cancer Center / Stormont Vail Health is a medical facility located in Topeka, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Lymphoma, Leukemia and other specialties. Cotton O'Neil Cancer Center / Stormont Vail Health is involved with conducting 158 clinical trials across 197 conditions. There are 5 research doctors associated with this hospital, such as Mehmood H. Hashmi, David E. Einspahr, Brandon R. Weckbaugh, and Daulath Singh.

Top PIs

Clinical Trials running at Cotton O'Neil Cancer Center / Stormont Vail Health

Lung Cancer

Breast Cancer

Colorectal Cancer

Bladder Cancer

Multiple Myeloma

Prostate Cancer

Acute Myeloid Leukemia

Non-Small Cell Lung Cancer

Lymphoma

Melanoma

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Cannabis Use

for Breast Cancer

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

Recruiting

1 award

N/A

10 criteria